Long-Term Improvements in Health-Related Quality of Life of Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Results from the CIMPASI-1 and CIMPASI-2 Phase 3 Trials. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s20. Available from: https://skin.dermsquared.com/skin/article/view/1173